Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Furst

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Arthritis Care & Research|October 26, 2012
Reply: To PMID 22473917Jasvinder A Singh, Kenneth G Saag, Daniel Furst
Seminars in Arthritis and Rheumatism|November 23, 2013
Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrumsGeraldine Navarro, Sara Taroumian, Nashla Barroso, et al.
Arthritis and Rheumatism|December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposesFrederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.
Transplant Immunology|December 21, 2011
Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICAGhasem Solgi, Daniel Furst, Joannis Mytilineos, et al.
Rheumatology and Therapy|November 10, 2021
Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19Andrew J Holman, Edward Keystone, Ernest Choy, et al.
Scientific Reports|July 1, 2016
Wide-field imaging of birefringent synovial fluid crystals using lens-free polarized microscopy for gout diagnosisYibo Zhang, Seung Yoon Celine Lee, Yun Zhang, et al.
IEEE Transactions on Visualization and Computer Graphics|November 21, 2025
Understanding Large Language Model Behaviors through Interactive Counterfactual Generation and AnalysisFurui Cheng, Vilem Zouhar, Robin Shing Moon Chan, et al.
Arthritis and Rheumatism|October 1, 2004
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritisThierry Dervieux, Daniel Furst, Diana Orentas Lein, et al.
Environmental Toxicology and Chemistry|February 11, 2025
Effects of perfluorooctane sulfonate (PFOS) on a novel reptilian toxicity test species, the brown anole (Anolis sagrei)Christopher J Salice, Andrew East, Caitlin Weible, et al.
European Journal of Rheumatology|June 8, 2021
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studiesMark C Genovese, Patrick Durez, Roy Fleischmann, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Arthritis Care & Research|October 26, 2012
Reply: To PMID 22473917Jasvinder A Singh, Kenneth G Saag, Daniel Furst
Seminars in Arthritis and Rheumatism|November 23, 2013
Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrumsGeraldine Navarro, Sara Taroumian, Nashla Barroso, et al.
Arthritis and Rheumatism|December 2, 2005
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposesFrederick Wolfe, Kaleb Michaud, Theodore Pincus, et al.
Transplant Immunology|December 21, 2011
Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICAGhasem Solgi, Daniel Furst, Joannis Mytilineos, et al.
Rheumatology and Therapy|November 10, 2021
Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19Andrew J Holman, Edward Keystone, Ernest Choy, et al.
Scientific Reports|July 1, 2016
Wide-field imaging of birefringent synovial fluid crystals using lens-free polarized microscopy for gout diagnosisYibo Zhang, Seung Yoon Celine Lee, Yun Zhang, et al.
IEEE Transactions on Visualization and Computer Graphics|November 21, 2025
Understanding Large Language Model Behaviors through Interactive Counterfactual Generation and AnalysisFurui Cheng, Vilem Zouhar, Robin Shing Moon Chan, et al.
Arthritis and Rheumatism|October 1, 2004
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritisThierry Dervieux, Daniel Furst, Diana Orentas Lein, et al.
Environmental Toxicology and Chemistry|February 11, 2025
Effects of perfluorooctane sulfonate (PFOS) on a novel reptilian toxicity test species, the brown anole (Anolis sagrei)Christopher J Salice, Andrew East, Caitlin Weible, et al.
European Journal of Rheumatology|June 8, 2021
Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studiesMark C Genovese, Patrick Durez, Roy Fleischmann, et al.
Pageof 4